A cannabis product with a very low level of THC and more CBD, up to 2.5 mg, is ideal. This cautiousness can help avoid injuries, such as falls, Dr. Fitzcharles says.
“Start with a tiny dose at nighttime, and see how [the patient] feels, but with the knowledge that even a tiny amount of THC can cause psychomotor effects,” she says.
4. Encourage patients to understand what they’re purchasing and to get it from licensed provider or dispensary.
This approach makes it easier for patients to get a product without unpredictable THC levels or contaminants.
Dr. Fitzcharles says she also emphasizes good lifestyle choices for better pain management, such as a balanced diet, a healthy weight, more physical activity and adequate sleep, with her patients.
Vanessa Caceres is a medical writer in Bradenton, Fla.
References
- State medical cannabis laws. National Conference of State Legislatures. 2023.
- Fitzcharles MA, Rampakakis E, Sampalis JS, et al. Use of medical cannabis by patients with fibromyalgia in Canada after cannabis legalization: A cross-sectional study. Clin Exp Rheumatol. 2021 May–Jun;39 suppl 130(3):115–119.
- Fitzcharles M A, Niaki OZ, Hauser W, et al. Position statement: A pragmatic approach for medical cannabis and patients with rheumatic diseases. J Rheumatol. 2019 May;46(5):532–538.
More Episodes
A new episode of ACR on Air comes out twice a month. Listen to this full episode and others online at acronair.org. Or download and subscribe wherever you get your podcasts.
